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Vinylboronic acid-caged prodrug activation using
click-to-release tetrazine ligation†
Lianne P. W. M. Lelieveldt, Selma Eising, Abel Wijen and Kimberly M. Bonger *
Bioorthogonal reactions can be performed selectively in the pres-
ence of any biological functional group and are widely used to
achieve site-selective chemical modiﬁcations of biomolecules.
The click-to-release reaction is a bioorthogonal bond-cleavage
variant that has gained much interest over the last few years. The
bioorthogonal reaction between tetrazines and trans-cyclooctenes
or vinyl ethers, for example, initiates the release of a small mole-
cule immediately after the cycloaddition with tetrazines. Recently,
our group reported that vinylboronic acids (VBAs) give exception-
ally high reaction rates in the bioorthogonal inverse electron-
demand Diels–Alder reaction with tetrazines that are substituted
with boron-coordinating ligands. In the present study, we show
that VBAs can be used in a click-to-release variant and demon-
strate its bioorthogonality with a VBA-protected doxorubicin
prodrug. We show that the cytotoxicity of doxorubicin is silenced
by the attachment of the VBA, and activity can be largely restored
upon the reaction with a tetrazine, inducing cell death.
Introduction
Chemical site-selective protein modifications have become
increasingly popular for modification and control over protein
functions in vitro and in living systems. Several reactions have
been developed to decorate biomolecules with a desired func-
tionality such as fluorophores, aﬃnity probes or reactive tags.
All these reactions have some properties in common as they
must be selective over other functional groups in bio-
molecules, have fast reaction rates and proceed in aqueous
media around physiological pH.1 Reactions such as the strain-
promoted alkyne–azide cycloaddition (SPAAC)2 or the inverse
electron-demand Diels–Alder reaction with tetrazines3 have
been used extensively for modifying purposes. Our group has
recently reported a new bioorthogonal tetrazine ligation utiliz-
ing vinylboronic acids (VBAs).4–7 We showed that by introdu-
cing a boronic acid moiety on an alkene, reaction rates of an
inverse electron-demand Diels–Alder (iEDDA) reaction with
pyridyl-containing tetrazines improved by several orders of
magnitude compared to the non-modified linear alkene.4 The
hydrophilic properties and the small size of VBAs compared to
other bioorthogonal reactants make them attractive for use in
biomolecular labeling experiments. VBAs were shown to be
biocompatible, non-toxic, and highly stable in aqueous media
and cell lysates. In addition, while the number of bioorthogo-
nal reactions used in situ and in vivo is limited due to the need
for toxic reagents (e.g. copper, in copper(I)-catalyzed alkyne–
azide cycloaddition8) or possible side reactions of the reactants
(e.g. strained alkenes or alkynes can react with cysteines9),
VBAs appeared to be useful in cellular experiments.7 Reactions
with vicinal diols, present in carbohydrates for example, were
not observed when performing reactions in living cells.
The reactivity of VBAs depends on the tetrazine and its sub-
stituents. Since the boronic acid coordinates to the pyridyl ring
of dipyridyl-s-tetrazine, reaction rates were enhanced in com-
parison with tetrazines lacking such a potential Lewis base.6
This unique feature allows one to perform orthogonal
bioorthogonal reactions with two diﬀerent tetrazines, one with
and one without substituents allowing for coordination, and
using a VBA and a strained alkene.
The interest in bioorthogonal bond-cleavage reactions for
activation of protected biologically relevant molecules in vivo
has increased significantly (Fig. 1A). A substantial number of
so-called ‘click-to-release’ reactions have been developed in the
last few years.10–12 These reactions enable new applications
in vitro and in vivo, such as the activation of prodrugs or
fluorogenic compounds. Most reactions are based on the
iEDDA reaction between a tetrazine and a (strained) alkene.11
In 2013, the group of Robillard reported the first bioortho-
gonal click-to-release reaction based on the reaction of tetra-
zines with trans-cyclooctenes (TCOs) that possess a carbamate
substituent at the allylic position (Fig. 1A).13 After the iEDDA
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reaction of the tetrazine and TCO, the 4,5-dihydropyridazine
eliminates the leaving group to liberate both CO2 and the
amine. Unfortunately, part of the dihydropyridazine tauto-
merizes to the 1,4-dihydropyridazine, which does not lead to a
release reaction and therefore this click-to-release process did
not result in complete elimination. Over the last few years, the
reaction has been optimized14,15 and the scope was further
expanded16 and applied in biological systems for activation of
prodrugs,17–23 RNA24 or caged proteins.14,25,26 Recently, it was
noted that this click-to-release reaction is environmentally sen-
sitive and improvements on both the TCO and tetrazine
resulted in ultrafast click-to-release reaction rates and the com-
plete elimination of the leaving group.27
In 2016 and 2017, the groups of Devaraj and Bernardes
reported both the bioorthogonal click-to-release reactions of
tetrazines and vinyl ethers (Fig. 1A).28,29 These alkenes bear
their leaving group directly on the alkene and therefore this
results in immediate full release of the alcohol after the iEDDA
reaction. The vinyl ethers appeared to be stable in aqueous
solutions for at least 8 hours and were suitable for the release
of a prodrug in living cells.30 The vinyl ethers have the advan-
tage of being small in size, but have disappointingly low rate
constants when reacting with tetrazines.
Since VBAs have proven to be useful in bioorthogonal con-
jugation, we envisioned that by introducing a boronic acid
group on the vinyl ethers, we could increase the rate of these
click-to-release reactions. In addition, similar to vinyl ethers,
we expect that VBA ethers fully release the alcohol, or the
amine when linked via a carbamate, after the iEDDA reaction.
The proposed iEDDA click-to-release reaction mechanism of
vinylboronic acids with tetrazines is shown in Fig. 1B. Upon
cycloaddition and retro-Diels–Alder reaction, N2, the boric acid
and the uncaged drug are released. We here explore the appli-
cability of the VBA click-to-release strategy and develop a syn-
thetic route to VBA protected prodrugs, which can be released
using a tetrazine in the presence of cells.
Results and discussion
We first aimed to compare the reactivity of the VBA ether with
the unsubstituted vinyl ethers and synthesized VBA 6 and its
primary alkene derivative 9 (Scheme 1). The synthesis of VBA 6
started with the etherification of 4-hydroxybenzyl alcohol 1
with trichloroethylene and subsequent silyl protection of the
primary alcohol. Next, dichlorovinyl ether 3 was treated with
n-BuLi to eliminate hydrogen chloride and to provide alkynyl
ether 4. Deprotection of the primary alcohol and hydrobora-
tion of alkyne 5 with pinacolborane yielded VBA pinacol ester
6. In our kinetic experiments, we used the pinacol ester as a
precursor for the free boronic acid as it hydrolyzes quickly in
aqueous media (see Fig. SI-1†). The synthesis of vinyl ether 9
was performed following a literature procedure.31 Here,
4-hydroxybenzaldehyde (7) was first reacted with 1,2-dibro-
moethane to yield compound 8 which was subsequently elimi-
nated using t-BuOK and the aldehyde was reduced using
NaBH4 to yield the corresponding benzyl alcohol 9.
Having alkenes 6 and 9 in hand, we examined the second-
order rate constants with 3,6-dipyridyl-s-tetrazine 10 in 75%
MeOH in PBS at a controlled temperature of 20 °C (Fig. 2A). As
we used the pinacol ester as a precursor, we incubated ester 6
for 2 h in the solvent mixture to achieve full hydrolysis to the
free boronic acid before measuring its k2 value. Second-order
rate constants were obtained by following the decrease of the
tetrazine UV absorbance in the visible region. The pseudo
first-order constant kobs was first determined by plotting the
decay of tetrazine absorbance against time (minutes) for five
diﬀerent amounts of excess alkene (see also the ESI†). Next,
the kobs was plotted against the five diﬀerent alkene concen-
trations and a linear regression fit gave the linear function, of
which the slope corresponded to the k2 (Fig. SI-2†). The
second-order rate constant for VBA 6 was 3.3 × 10−3 M−1 s−1
and 4-fold higher than the rate constant of vinyl ether 9,
clearly indicating a positive eﬀect of the boronic acid on the
reactivity of the alkene.
The observed rate constant of VBA ether 6 was lower than
expected as we previously observed rate enhancements of up to
100-fold compared to the unsubstituted alkene derivatives.4
We hypothesize that the moderate rate enhancement is due to
Fig. 1 (A) General scheme of a click-to-release reaction to uncage a
prodrug. (B) Overview of the inverse electron-demand Diels–Alder
cycloaddition with a tetrazine and a vinyl ether or vinylboronic acid to
release an alcohol functionality.
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Scheme 1 Synthesis of VBA ether 6 and vinyl ether 9. (a) Trichloroethylene, K2CO3, DMF, 70 °C, 16 h, 87%. (b) TBSCl, imidazole, DMF, 2 h, quant. (c)
n-BuLi, Et2O, −78 to −40 °C, 87%. (d) TBAF, THF, 0 °C, 91%. (e) Pinacolborane, RuHClCO(PPh3)3, toluene, 50 °C, 16 h, 76%. (f ) Dibromoethane,
K2CO3, MeCN, reﬂux, 20 h, 79%. (g) t-BuOK, DMSO, r.t., 10 min. (h) NaBH4, MeOH, r.t., 1.5 h, 18%.
Fig. 2 Click-to-release reactions and reaction rates. (A) Scheme of the reaction of 3,6-dipyridyl-s-tetrazine Tz with VBA ether 6 and vinyl ether 9.
k2 values were measured in 3 : 1 MeOH/PBS; (B)
1H-NMR study of the reaction between tetrazine 10 ( ) and VBA ether 6 ( ) yielding pyridazine 11
( ) and 4-hydroxybenzyl alcohol 1 ( ) in 3 : 1 CD3OD/deuterated PBS; (C) similar to (B) with the reaction of Tz with vinyl ether 9 ( ).
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the ether on the vinylic position. Since this alcohol is slightly
electron-donating, we assume that the alkene becomes more
electron-rich, thereby lowering the acidity of the boronic acid,
resulting in less favorable coordination to the pyridyl substitu-
ents of the tetrazine.32
Next, we looked in more detail into the click-to-release reac-
tion of 3,6-dipyridyl-s-tetrazine 10 and alkenes 6 and 9 by 1H
NMR spectroscopy in 75% CD3OD in deuterated PBS over time
(Fig. 2B and C). A near to complete conversion of VBA ether 6
was observed after 7 days, while vinyl ether 9 gave around 50%
conversion. Both reactions resulted in the clean formation of
pyridazine 11 and 4-hydroxybenzyl alcohol 1. No intermediates
were observed showing that the initial cycloaddition step is
rate limiting for both VBA ether 6 and vinyl ether 9.
To further examine the click-to-release reaction with a VBA
ether in a more complex system, we synthesized a VBA-caged
cytotoxin doxorubicin and explored the eﬀect on HeLa cells
upon addition of a water soluble tetrazine 12 (Fig. 3A). For
this, we aimed to couple doxorubicin to VBA alcohol 6, which
acts as a self-cleavable linker by 1,6 elimination upon release
(Fig. 3B).33 We commenced the synthesis from VBA alcohol 6
and activated the alcohol using bis(pentafluorophenyl)carbon-
ate and Et3N as a base, yielding successfully VBA-PFP carbon-
ate 13. Doxorubicin was subsequently added and reacted over-
night to obtain VBA-caged doxorubicin 14 (VBA-Dox) in reason-
able yields.
First, we tested the stability of the VBA-Dox 14 at 100 µM in
PBS at 37 °C before performing the click-to-release reactions
with cells. As shown in Fig. SI-3,† hydrolysis of the pinacol
ester was observed, as expected, while minor decomposition
(around 10%) of VBA-Dox 14 was observed after 48 hours.
Decomposition likely results from protodeboronation of the
VBA cage.34 Importantly, no free doxorubicin was observed
after incubating VBA-Dox 14 in PBS for up to 7 days.
Encouraged by these results we next evaluated the cyclo-
addition with a water soluble tetrazine 12 and followed the
subsequent release over time in a buﬀer system with LCMS.
Deprotection of 14 at 100 µM in PBS at 37 °C, using 1 equi-
valent of tetrazine 12 resulted in decaging and release of doxo-
rubicin (Fig. SI-4†). No intermediate products were observed,
indicating that the cleavage of the linker occurred instan-
taneously after the cycloaddition.
Next, we tested the VBA release and toxicity of doxorubicin
on living HeLa cells (Fig. 3A). We first incubated HeLa cells
with free doxorubicin and observed a dose dependent toxic
eﬀect, as expected (Fig. SI-5†). In addition, we incubated VBA-
caged doxorubicin in the absence of a tetrazine. No toxicity
was observed with 100 nM VBA-doxorubicin 14 while 1 µM
Fig. 3 Click-to-release reaction of VBA-Dox 14 to yield the free doxorubicin. (A) General overview of the caging strategy. (B) Synthetic route of
VBA-Dox. (a) Bis(pentaﬂuorophenyl)carbonate, Et3N, r.t., 1 h, 84%. (b) Doxorubicin HCl, Et3N, DMF, r.t., 24 h, 40%. (C) Evaluation of cytotoxicity of
VBA-Dox 14 incubated with tetrazine 12 (1 or 10 µM, respectively, 10 equiv. or 100 equiv.) for 72 h with HeLa cells.
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VBA-Dox did show some toxicity after 3 days of incubation. As
we observed more than 70% cell death with free doxorubicin
at the lower concentration of 100 nM we used these conditions
to test the eﬃciency of the VBA click-to-release strategy with
tetrazine 12.
We incubated VBA-doxorubicin 14 with 10 and 100 equiva-
lents of tetrazine 12 with HeLa cells for 3 days. To our delight,
we observed a dose-dependent toxicity of tetrazine-activated
doxorubicin and an almost similar toxicity level was obtained
to that when incubated with free doxorubin (Fig. 3C). Using
higher amounts of tetrazine 12 also showed signs of toxicity of
the tetrazine itself, so we omitted this concentration in further
cell studies (Fig. SI-5†).
Conclusion
In this work we have shown that VBAs can be used in bioortho-
gonal click-to-release tetrazine ligations. The release was
instantaneous after the tetrazine cycloaddition as no reaction
intermediates were observed by NMR experiments. We assume
that the slight electron-donating nature of the ether at the
vinylic position of the boronic acid reduces the reaction rate as
compared to VBAs lacking the ether functionality. The boronic
acid moiety increases the reactivity of vinyl ethers in the click-
to-release tetrazine ligation several folds when tetrazines
bearing boron-coordinating ligands are used.
The use of VBA-caged prodrugs may be of interest as we
have recently shown that this moiety can orthogonally react
with tetrazines bearing a coordinating phenol substituent.
These tetrazines are too electron rich to react with vinyl
ethers.5 It would further be interesting to explore diﬀerent sub-
stituents on the VBA cage, such as carbamates, to study the
electronic eﬀects in the click-to-release reaction with diﬀerent
coordinating tetrazines. These studies are currently ongoing in
our laboratory.
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